Challenges and Opportunities in the Management of Advanced Gastric Cancer

Access Course



Dr Ajani examines the emerging use of immunotherapy in the management of advanced gastric cancer via 2 patient cases.

This activity is intended for oncologists, gastroenterologists, and surgeons.

The goal of this activity is to discuss the latest advances in the use of immunotherapy in patients with advanced gastric cancer.




Approximate Time to Complete: 30 minutes


Credit Available: Dec. 14, 2017 - Dec. 14, 2018


Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Have increased knowledge regarding the emerging clinical trial data on the management of gastric cancer
  • Have greater competence related to selecting the most appropriate treatment regimen in patients with gastric cancer through the continuum of care
  • Have greater competence related to managing treatment-related adverse events in patients with gastric cancer
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 1.00
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 1.00